Reduction in sclerotic graft-versus-host-disease after post-transplant cyclophosphamide-based regimen comapared to traditional tacrolimus-based regimens in allogeneic hematopoietic cell transplant recipients: a retrospective cohort study

Supplementary materials for "Reduction in sclerotic graft-versus-host-disease after post-transplant cyclophosphamide-based regimen comapared to traditional tacrolimus-based regimens in allogeneic hematopoietic cell transplant recipients: a retrospective cohort study"《异基因造血细胞移植受者（allogeneic hematopoietic cell transplant recipients）中，移植后以环磷酰胺为基础的治疗方案（post-transplant cyclophosphamide-based regimen）相较于传统他克莫司治疗方案（traditional tacrolimus-based regimens）可降低硬化性移植物抗宿主病（sclerotic graft-versus-host-disease）发生率：一项回顾性队列研究（retrospective cohort study）》一文的补充材料